BCM
MAIA icon

Brookstone Capital Management’s MAIA Biotechnology MAIA Stock Holding History

Brookstone Capital Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,658
Closed -$14.8K – 941
2023
Q4 		$14.8K Buy
+12,658
New +$20.4K ﹤0.01% 861

Other funds holding MAIA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brookstone Capital Management's MAIA Position: Q1 2024 in Review

Brookstone Capital Management sold out of MAIA Biotechnology (MAIA) in Q1 2024, closing a stake of 12,658 shares — an estimated $14.8K sold.

Brookstone Capital Management first reported a position in MAIA in Q4 2023 and held it in 1 quarter. The position peaked at $14.8K in Q4 2023. 20 funds tracked by Wall St. Rank hold MAIA as of Q1 2024.

  • Brookstone Capital Management reported no remaining MAIA Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Brookstone Capital Management sold 12,658 MAIA Biotechnology shares in Q1 2024, an estimated $14.8K.
  • Brookstone Capital Management first reported a position in MAIA Biotechnology in Q4 2023 and held it in 1 quarter.
  • Brookstone Capital Management's MAIA Biotechnology position peaked at $14.8K in Q4 2023.
  • 20 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2024.

Based on Brookstone Capital Management's 13F filing for Q1 2024, filed 15 Apr 2024.